Malignant Bone Marrow Neoplasm — Trials

Malignant Bone Marrow Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,612 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,035
Recruiting: 592
Ph III recruiting: 61
Growth YoY: +8.1%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (801)

clinicaltrialsPublishedShowing 301–350 of 512 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07505160	Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients	not yet recruiting	Phase 2	35	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Apr 1, 2026	clinicaltrials
NCT03286530	Ruxolitinib + Allogeneic Stem Cell Transplantation in AML	active not recruiting	Phase 2	64	Massachusetts General HospitalOTHER	1	Mar 27, 2026